Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Yale University: Clinical Trials & FDA Approval Profile

Yale University (Global / Institutional) sponsors 146 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 80 active protocols (56 recruiting now), 36 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)20.6%
Median Closed Enrollment vs National (145 pts)47 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Yale University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)146
Active Pipeline (Recruiting Now)80 (56)
Completed vs Stopped Early36 / 30 (20.6%)
Median Closed Actual Enrollment47 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Yale University
Hospital Research SiteLocationShared Protocols
Yale Cancer Center and Smilow Cancer HospitalNew Haven, CT118
Johns Hopkins Hospital and Kimmel Cancer CenterBaltimore, MD7
University of Pennsylvania Abramson Cancer CenterPhiladelphia, PA6

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Yale University
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06996652An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in PersPhase IIRECRUITING
NCT06923527Circulating Tumor DNAPhase IIRECRUITING
NCT03907046Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase IIIRECRUITING
NCT04924322Catheter-Related Early Thromboprophylaxis With Enoxaparin StudiesPhase II/IIIRECRUITING
NCT03456843Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerPhase IIACTIVE NOT RECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Yale University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI